Explore the injection
experience
SIMPONI® has to offer
For adults with:
For adults with:
NOW APPROVED
© Johnson & Johnson and its affiliates 2025 10/25 cp-538889v1
SIMPONI® (golimumab) is now approved in children weighing at least 33 pounds (15 kg) with moderately to severely active ulcerative colitis.
TALK TO YOUR HEALTHCARE PROVIDER
ABOUT SIMPONI®
Please read the full Prescribing Information, including Boxed Warning and Medication Guide for SIMPONI®. Please see the full Important Safety Information below.
© Johnson & Johnson and its affiliates 2025 10/25 cp-538889v1
